Requirements for ethics committee review for studies submitted to Implementation Science MP Eccles, C Weijer, B Mittman Implementation science 6, 1-3, 2011 | 2133 | 2011 |
Protecting communities in biomedical research C Weijer, EJ Emanuel Science 289 (5482), 1142-1144, 2000 | 350 | 2000 |
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration K Hemming, M Taljaard, JE McKenzie, R Hooper, A Copas, JA Thompson, ... bmj 363, 2018 | 349 | 2018 |
Informing study participants of research results: an ethical imperative CV Fernandez, E Kodish, C Weijer IRB: Ethics & Human Research 25 (3), 12-19, 2003 | 349 | 2003 |
The Ottawa statement on the ethical design and conduct of cluster randomized trials C Weijer, JM Grimshaw, MP Eccles, AD McRae, A White, JC Brehaut, ... PLoS medicine 9 (11), e1001346, 2012 | 292 | 2012 |
Protecting communities in research: current guidelines and limits of extrapolation C Weijer, G Goldsand, EJ Emanuel Nature genetics 23 (3), 275-280, 1999 | 291 | 1999 |
The ethical analysis of risk C Weijer Journal of Law, Medicine & Ethics 28 (4), 344-361, 2000 | 264 | 2000 |
When are research risks reasonable in relation to anticipated benefits? C Weijer, PB Miller Nature medicine 10 (6), 570-573, 2004 | 241 | 2004 |
Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trialForAgainst C Weijer, MW Enkin, SH Shapiro, KC Glass Bmj 321 (7263), 756-758, 2000 | 230 | 2000 |
Guidelines for reporting trial protocols and completed trials modified due to the COVID-19 pandemic and other extenuating circumstances: the CONSERVE 2021 statement AM Orkin, PJ Gill, D Ghersi, L Campbell, J Sugarman, R Emsley, PG Steg, ... Jama 326 (3), 257-265, 2021 | 212 | 2021 |
Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8 NM Ivers, M Taljaard, S Dixon, C Bennett, A McRae, J Taleban, Z Skea, ... Bmj 343, 2011 | 202 | 2011 |
Protecting communities in research: philosophical and pragmatic challenges C Weijer Cambridge Quarterly of Healthcare Ethics 8 (4), 501-513, 1999 | 200 | 1999 |
How to design efficient cluster randomised trials K Hemming, S Eldridge, G Forbes, C Weijer, M Taljaard bmj 358, 2017 | 199 | 2017 |
In loco parentis minimal risk as an ethical threshold for research upon children B Freedman, A Fuks, C Weijer The Hastings Center Report 23 (2), 13-19, 1993 | 198 | 1993 |
Placebo orthodoxy in clinical research II: ethical, legal, and regulatory myths B Freedman, KC Glass, C Weijer Journal of Law, Medicine & Ethics 24 (3), 252-259, 1996 | 195 | 1996 |
Ethical issues posed by cluster randomized trials in health research C Weijer, JM Grimshaw, M Taljaard, A Binik, R Boruch, JC Brehaut, ... Trials 12, 1-11, 2011 | 156 | 2011 |
Placebo orthodoxy in clinical research I: empirical and methodological myths B Freedman, C Weijer, KC Glass Journal of Law, Medicine & Ethics 24 (3), 243-251, 1996 | 151 | 1996 |
Rehabilitating equipoise PB Miller, C Weijer Kennedy Institute of Ethics Journal 13 (2), 93-118, 2003 | 145 | 2003 |
Ethical criteria for human challenge studies in infectious diseases B Bambery, M Selgelid, C Weijer, J Savulescu, AJ Pollard Public health ethics 9 (1), 92-103, 2016 | 125 | 2016 |
When is informed consent required in cluster randomized trials in health research? AD McRae, C Weijer, A Binik, JM Grimshaw, R Boruch, JC Brehaut, ... Trials 12, 1-13, 2011 | 116 | 2011 |